Patients were randomly assigned to receive oral paricalcitol or placebo. Dosing took place three times weekly, starting at 2 µ g or 4 µ g per dose (two trials) or once daily, starting at 1 µ g ...

This study evaluated the health-economic consequences of use of intravenous paricalcitol (Zemplar ®), oral calcitriol or oral and intravenous alfacalcidol for the treatment of patients with ...

Paricalcitol 1mcg, 2mcg; soft gel caps. Take without regard to food. <10yrs: not established. 10–16yrs: CKD Stages 3/4: initially 1mcg 3 times weekly (no more often than every other day).

The vitamin D receptor activator (VDRA) paricalcitol produced a similar reduction in serum PTH levels to that achieved by cinacalcet in patients with stages 3–4 CKD, but with no notable increase ...